Horizon Discovery The Myeloid DNA Reference Standard is the first-to-market, large cell-line derived, myeloid cancer reference standard designed to enable faster, more reliable, and more cost-effective assay validation, to support the market in bringing routine testing into practice. This standard has been developed using Horizon’s specialist gene-editing technology, to deliver a cell line-derived reference standard […]
The post Cancer Reference Standard appeared first on GEN - Genetic Engineering and Biotechnology News.
Original Article: Cancer Reference Standard